Abstract
Since the COVID-19 outbreak, studies across diverse countries have strongly pointed toward the emergence of a mental health crisis, with a dramatic increase in the prevalence of depressive psychopathology and suicidal tendencies. Vitamin D deficiency has been associated with an increased risk of mental health problems as well as individual responses to stress. Studies have discussed the relationship between low serum vitamin D concentrations and depressive symptoms, suggesting that maintaining adequate concentrations of serum vitamin D seems to have a protective effect against it. Vitamin D was found to contribute to improved serotonergic neurotransmission in the experimental model of depression by regulating serotonin metabolism. The signaling of 1,25-dihydroxyvitamin D3, the active form of vitamin D, through vitamin D receptor (VDR) induces the expression of the gene of tryptophan hydroxylase 2 (TPH2), influences the expression of serotonin reuptake transporter (SERT) as well as the levels of monoamine oxidase-A (MAO-A), the enzyme responsible for serotonin catabolism. Vitamin D also presents a relevant link with chronobiological interplay, which could influence the development of depressive symptoms when unbalance between light-dark cycles occurs. In this Perspective, we discussed the significant role of vitamin D in the elevation of stress-related depressive symptoms during the COVID-19 pandemic. It is suggested that vitamin D monitoring and, when deficiency is detected, supplementation could be considered as an important healthcare measure while lockdown and social isolation procedures last during the COVID-19 pandemic.
Role of vitamin D in the development of depressive symptoms. The synthesis of vitamin D from sunlight is impaired by lockdown and social distance measures imposed by the governments around the world during COVID-10 pandemic. Endogenous vitamin D synthesis initiates in the skin when 7-dehydrocholesterol (7-DHC) is converted in pre-vitamin D3 and then vitamin D3 [25(OH)D3]. It is transported through blood circulation by the vitamin D binding protein (VDBP) to the liver, the kidney, and the brain, where can be converted in its the active form [1,25(OH)2D3]. In the brain, the biological effects of 1,25(OH)2D3 are largely mediated by vitamin D receptor (VDR) through genomic mechanisms, which influence several aspects of serotonin metabolism, such as increasing serotonin synthesis by induction of the tryptophan hydroxylase 2 (TPH2) gene expression; influencing the expression of serotonin reuptake transporter (SERT) and the levels of monoamine oxidase-A (MAO-A), responsible to serotonin catabolism; and indirectly may regulate the synthesis of melatonin that improve the circadian rhythm. This mechanism can be impaired during social isolation and consequent reduction of vitamin D due to low sun exposure during the pandemic, which could contribute to the development of depressive symptoms.
Depression and COVID-19 Pandemic
The current pandemic of coronavirus (COVID-19) has imposed social isolation measures, forcing many people to stay confined at home, canceling routine outdoor activities (working routine, sidewalks, exercises in fitness centers, and park visits), and limiting social interaction among friends, coworkers, and family. A study concentrated on a general population from China within the first 2 weeks of the COVID-19 outbreak indicated that the lifestyle changes prompted individuals to stay indoors for over 20–24 h per day ().
Since the COVID-19 outbreak, studies across diverse countries have strongly pointed toward the emergence of a mental health crisis, with a dramatic increase in the prevalence of depressive psychopathology and suicidal tendencies. A systematic review of the instances of mental health conditions during the period of the COVID-19 pandemic showed that the prevalence of depressive symptoms ranged from 14.6 to 48.3% across all populations (China, Spain, Italy, Iran, the United States, Turkey, Nepal, and Denmark) (). In the United States, the prevalence of symptoms associated with depression increased more than threefold during the COVID-19 pandemic compared to the times before the viral outbreak (8.5% before to 27.8% during COVID-19) (). In London, after lockdown the prevalence of feeling worse on the depression was 12.8% and to anxiety was 12.3% in people with 50 years or over (). Restriction of public circulation and social isolation, despite those being essential measures to contain the pandemic, has been postulated to be responsible for increased stress, loneliness, and unhealthy lifestyle habits (; ).
Recently, a longitudinal study involving older adults () demonstrated that social disconnectedness could contribute to a greater risk of depression and anxiety, which has also been reported in adolescent and adult populations (). In a survey conducted by UNICEF, Australia on 1,000 young people (aged 13–17 years), almost half of the respondents asserted that COVID-19 had negatively affected their levels of stress and anxiety. An elevated level of stress, fear, irritability, frustration, and boredom was reported by individuals who were in social isolation and had experienced a major deflection from their usual routine and interaction with other people (). In addition to the increase in the risk of mental health problems, the pandemic has also exacerbated preexisting psychiatric conditions. Vulnerability to psychological stress might depend on social support, isolation time, COVID-19 infection-related factors, the amount of mass media exposure, physical activity, and eating patterns ().
Vitamin D and Sunlight Exposure: Breakdown by Social Isolation Measures During COVID-19 Pandemic
Vitamin D deficiency has been associated with an increased risk of mental health problems as well as individual responses to stress (). There are several risk factors related to vitamin D deficiency such as obesity, dark skin, living in countries with low sunlight incidence, gastrointestinal malabsorption, renal insufficiency, liver disease, and the use of covered clothing and sunscreen (; ). Furthermore, reduced exposure to sunlight, thereby reducing the biosynthesis of vitamin D in the skin, is a strong factor in the pathophysiology of vitamin D deficiency and studies have been demonstrated that sun exposure can enhance vitamin D synthesis (; ; ; ).
After adequate exposure to sunlight, the conversion of 7-dehydrocholesterol (7-DHC) to 25-hydroxycholecalciferol [25(OH)D] takes approximately 8 h and an additional time to enter the dermal capillary bed. The daily exposure of 20% of the body surface is sufficient to increase 25(OH)D, which points toward the importance of sunlight in the maintenance of vitamin D levels at the appropriate concentration (). The half-life of 25(OH)D was estimated to 15 to 25 days, approximately (; ). The half-life of serum 25(OH)D was estimated to be ∼82 days when calculated after one single loading dose of 100 000 IU of cholecalciferol was administered at the beginning of the study, followed by a daily dose of 4800 IU from days 7 to 20, and none from day 21 (). In Nordic countries, which experience low amounts of sunlight, vitamin D concentrations were found to be reduced by 20 to 40% during the winter (). These data suggest that vitamin D supplementation is crucial in individuals who experience long periods of indoor activities and/or low sunshine exposure.
Social isolation and lockdown measures caused a reduction in the time spent outdoors and possibly less exposure to sunlight necessary to maintain vitamin D concentrations. When associated with a change in eating habits, with a predominance of meals ordered through food delivery joints, which have a reduced nutritional and vitamin D content, it could also reduce the daily amount of vitamin D for organism maintenance. One study conducted in Verona (Italy) during the COVID-19 pandemic, which intends to investigate whether social isolation could impact the vitamin D status of the general population, conclude that this was not an issue in Verona (the region in which data was collected) (). Despite scarce publications address this issue, research groups, and professionals already start to concern about vitamin D deficiency during the COVID-19 pandemic. Some postulate that home reclusion could lead to a surge of vitamin D deficiency around the world, which has been associated with developing type 2 diabetes, cognitive decline, malignant neoplasms, autoimmune diseases, cardiovascular diseases, osteoporosis, risk of fall in the elderly, and overall mortality (). In fact, the diminished vitamin D intake and sun exposure might result in severe manifestations since the worldwide prevalence of vitamin D deficiency had been documented as a health concern even before the pandemic (; Zhou et al., 2019; ).
Vitamin D and Depressive Symptoms
Vitamin D low levels have been previously associated with the risk of depressive symptoms and depression worldwide (; ; Yao et al., 2018; ; ). However, few publications have been discussing this relationship during the COVID-19 pandemic (; ). discussed that vitamin D can be hypothesized to trigger as well as sustain the psychiatric symptoms and can also be expected to alleviate the psychiatric manifestations in COVID-19. An observational study in Rome showed that low 25-hydroxyvitamin D serum levels were significantly associated with higher psychological distress in patients with mood disorders during the COVID-19 outbreak ().
The mechanisms associated with vitamin D antidepressant effects at the cellular level are under investigation in experimental studies, and some hypotheses have been presented in different reports in the literature. The VDR and some cytochrome P450 enzymes, which are responsible for the transformation of vitamin D into its active form, were found in cerebral cells and in brain areas that have been implicated in the pathophysiology of depression (). The optimal vitamin D status was found to contribute to improved serotonergic neurotransmission deficits in an experimental model of depression by regulating serotonin synthesis (). To increase serotonin concentrations, tryptophan must first be transported across the blood-brain barrier and metabolized by TPH2. The signaling of 1,25-dihydroxycholecalciferol [1,25(OH)2D3], the active form of vitamin D, through VDR induces the expression of the gene TPH2 (; ). Moreover, 1,25(OH)2D3 influences the expression of SERT as well as the levels of MAO-A, the enzyme responsible for serotonin catabolism ().
Another important aspect related to vitamin D and brain function is its link with chronobiological interplay. Indeed, the interface between vitamin D and the circadian system has been revealed as both plasma concentrations of 1,25(OH)2D3 and vitamin D binding protein (DBP) display circadian oscillation patterns (). However, available evidence suggests a mediatory role of vitamin D in the sleep-wake cycle, since the lower concentrations of vitamin D were correlated with impaired sleep quality and abbreviated sleep duration (; ). Melatonin, a hormone involved in the regulation of circadian rhythm, is synthesized from the metabolism of serotonin. The widespread presence of VDR has been documented in postmortem human brain samples, in areas involved in sleep regulation, which are also brain regions that showed the strongest expression of the enzyme 1-alpha-hydroxylase, enzymes responsible for the formation of 1,25(OH)2D3 (). In this way, it is possible to hypothesize that the chronic combined deficits of vitamin D and sleep-wake cycle impairment due to social isolation measures and lockdown might play an essential role as a modulator of amplified depressive symptomatology and/or the pathophysiology of major depressive disorder (MDD).
Depression has also been associated with mitochondrial dysfunctions and an increase in the formation of reactive oxygen species (ROS) inducing redox to unbalance and reduction in the energy production (adenosine triphosphate-ATP) (). Oxidative stress activates several transcription factors, such as nuclear factor kappa B (NF-kB) leading to the production of pro-inflammatory cytokines and other inflammatory molecules acting as potent inducers of inducible nitric oxide synthase (iNOS) (). Inflammation may induce depression through many mechanisms such as an alteration in the formation of key transmitters such as serotonin and an increase in Ca2+ signaling (; ). Also, dysfunction in mechanistic target of rapamycin (mTOR) signaling can lead to ROS production and the mTOR inhibition enhance sirtuin signaling contributing to mitochondrial integrity (). Vitamin D and melatonin share common signaling pathways that mediate homeostatic mitochondrial function, which includes the downregulation of mTOR, iNOS, and NF-κB pathways that are involved in increasing oxidative stress and cell damage. Also, Vitamin D and melatonin decrease oxidative stress by upregulation of sirtuin 1 (SIRT-1) and adenosine monophosphate-activated protein kinase (AMPK) pathways and activating antioxidant defense pathways by expression of antioxidant proteins. These pathways are crucial to avoid abnormal inflammatory responses related to oxidative stress and apoptosis ().
The studies aiming to investigate the antidepressant effect of vitamin D supplementation when depression was already diagnosed observed conflicting results (; ; ; ; Zhu et al., 2020). To mention some of them, in randomized clinical trials (RCT), , , and observed a reduction of depressive symptoms after vitamin D supplementation in patients with different stages of depression. Nevertheless, and Zhu et al. (2020) did not observe improvements in depressive symptoms after vitamin D supplementation. Data from a previous meta-analysis with RCT showed that supplementation with vitamin D (≥800 I.U. daily dose) had a positive effect when compared to the effect of antidepressants (). But, a separate meta-analysis did not support this evidence in adults and pointed out that the variability in methodological attributes of the studies included in the meta-analysis (differences in vitamin D doses, time of intervention duration, and assessment of depression) could influence the conclusions (). Despite all this uncertainty about the effects of vitamin D supplementation to treat depression, when the preventive effect of adequate concentrations of vitamin D was investigated in observational studies, the results are promising. Two systematic reviews and meta-analysis with population-based epidemiological studies (; ) showed an inverse association between serum 25(OH)D and the risk of depression and, in the pooled estimation analysis, an increase of 10 ng/mL in serum concentrations of vitamin D might have a protective effect against depression. The data from these two meta-analyses leads us to postulate that the monitoring of vitamin D during long periods of indoor activities associated with reduced time to sunlight exposure is a reasonable health measure, as well as the supplementation to maintain adequate vitamin D concentrations.
Vitamin D and COVID-19
A growing body of literature has been discussing a possible relationship between 25(OH)D and COVID-19, in which vitamin D may contribute to reducing the severity of illness caused by COVID-19 (; ; ; ; ). The main discussion is that Vitamin D could exert protective effects against respiratory infections, due to its immunomodulatory and anti-inflammatory roles, which have been highlighted in patients with community-acquired infections and acute respiratory failure (Zhou et al., 2019; ; ; ). COVID-19 has been shown to affect the neuroendocrine-immune system wherein it suppresses its activity. The neuroendocrine-immune system has been implicated in stress response and coping strategies ().
One study performed in vitro showed that the active form of Vitamin D, calcitriol, exhibits significant potent activity against SARS-CoV-2 in African green monkey kidney cells, human hepatoma cells, and human nasal epithelial cells (). In fact, the interest in the field has been growing and some systematic reviews and meta-analysis were performed to measure the risk of infection and severity of COVID-19 due to low levels of 25(OH)D in observational studies (; ; ; ; ). reported that severe cases of COVID-19 present 64% (OR = 1.64; 95% CI = 1.30–2.09) of vitamin D deficiency and that insufficiency increased hospitalization (OR = 1.81;95% CI = 1.41–2.21) and mortality (OR = 1.82; 95% CI = 1.06–2.58). found that vitamin D deficiency was a higher risk of SARS-CoV-2 infection (OR = 1.77; 95% CI = 1.24–2.53) and presented a higher severity (OR = 2.57; 95% CI = 1.65–4.01). showed that vitamin D deficiency or insufficiency also was associated with an increased risk of COVID-19 (OR = 1.43; 95% CI = 1.00–2.05). revealed that deficient vitamin D values showed a higher risk of COVID-19 infection (OR = 1.26; 95% CI = 1.19–1.34) and worse severity (OR = 2.6; 95% CI = 1.84–3.67) and higher mortality (OR = 1.22; 95% CI, 1.04–1.43). found that vitamin D deficiency was 80% more likely to acquire COVID-19 infection (OR = 1.80; 95%CI = 1.72–1.88).
Concerning clinical trials, only one systematic review and metanalysis were performed to identify the effect of vitamin D on COVID-19, and 32 clinical protocol was identified but only three studies have published results to-date and the results are controversial (). In fact, there are some challenges in vitamin D research and some authors have provided recommendations for the design of randomized clinical trials of vitamin D supplementation to prevent COVID-19 and to provide evidence-based guidance for clinicians and public health leaders ().
Conclusion
In the light of these evidence, it is possible to postulate that vitamin D deficiency could play a significant role in the elevation of stress-related depressive symptoms during the COVID-19 pandemic. It has been postulated that vitamin D is involved in the serotoninergic system, influencing serotonin metabolism and contributing to circadian rhythm maintenance, which are important aspects of the development of depressive symptoms. In order to reduce physical and mental health risks associated with vitamin D deficiency, it is suggested that vitamin D monitoring and, when deficiency is detected, supplementation could be considered as an important healthcare measure while lockdown and restrictive social isolation procedures last during the COVID-19 pandemic.
Statements
Data availability statement
The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.
Author contributions
All authors listed have made a substantial, direct and intellectual contribution to the work, and approved it for publication.
Funding
GC receive Ph.D. scholarship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-CAPES/Brazil (Finance Code 001).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AlaviN. M.KhademalhoseiniS.VakiliZ.AssarianF. (2019). Effect of vitamin D supplementation on depression in elderly patients: a randomized clinical trial.Clin. Nutr.382065–2070. 10.1016/j.clnu.2018.09.011
2
AlghamdiS.AlsulamiN.KhojaS.AlsufianiH.TayebH. O.TaraziF. I. (2020). Vitamin D supplementation ameliorates severity of major depressive disorder.J. Mol. Neurosci.70230–235. 10.1007/s12031-019-01461-2
3
AlpalhãoM.FilipeP. (2020). SARS-CoV-2 pandemic and vitamin D deficiency—a double trouble.Photodermatol. Photoimmunol. Photomed.36412–413. 10.1111/phpp.12579
4
AmreinK.ScherklM.HoffmannM.Neuwersch-SommereggerS.KöstenbergerM.Tmava BerishaA.et al (2020). Vitamin D deficiency 2.0: an update on the current status worldwide.Eur. J. Clin. Nutr.741498–1513. 10.1038/s41430-020-0558-y
5
BassatneA.BasbousM.ChakhtouraM.ZeinO. E.RahmeM.FuleihanG. E.-H. (2021). The link between COVID-19 and VItamin D (VIVID): a systematic review and meta-analysis.Metabolism154753. 10.1016/j.metabol.2021.154753
6
BergmanP. (2020). The link between vitamin D and COVID-19: distinguishing facts from fiction.J. Intern. Med.289131–133. 10.1111/joim.13158
7
BerridgeM. J. (2017). Vitamin D and depression: cellular and regulatory mechanisms.Pharmacol. Rev.6980–92. 10.1124/pr.116.013227
8
CamargoC. A.MartineauA. R. (2020). Vitamin D to prevent COVID-19: recommendations for the design of clinical trials.FEBS J.2873689–3692. 10.1111/febs.15534
9
CarusoG.BenattiC.BlomJ. M. C.CaraciF.TasceddaF. (2019). The many faces of mitochondrial dysfunction in depression: from pathology to treatment.Front. Pharmacol.10:995. 10.3389/fphar.2019.00995
10
CeolinG.MatsuoL. H.ConfortinS. C.D’OrsiE.RiegerD. K.MoreiraJ. D. (2020). Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil.Nutr. J.19:123. 10.1186/s12937-020-00638-5
11
ChalcraftJ. R.CardinalL. M.WechslerP. J.HollisB. W.GerowK. G.AlexanderB. M.et al (2020). Vitamin D synthesis following a single bout of sun exposure in older and younger men and women.Nutrients12:2237. 10.3390/nu12082237
12
ChelV. G. M.OomsM. E.PavelS.de GruijlF.BrandA.LipsP. (2011). Prevention and treatment of vitamin D deficiency in Dutch psychogeriatric nursing home residents by weekly half-body UVB exposure after showering: a pilot study.Age Ageing40211–214. 10.1093/ageing/afq159
13
Di NicolaM.DattoliL.MocciaL.PepeM.JaniriD.FiorilloA.et al (2020). Serum 25-hydroxyvitamin D levels and psychological distress symptoms in patients with affective disorders during the COVID-19 pandemic.Psychoneuroendocrinology122:104869. 10.1016/j.psyneuen.2020.104869
14
EttmanC. K.AbdallaS. M.CohenG. H.SampsonL.VivierP. M.GaleaS. (2020). Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic.JAMA Netw. Open3:e2019686. 10.1001/jamanetworkopen.2020.19686
15
EylesD. W.SmithS.KinobeR.HewisonM.McGrathJ. J. (2005). Distribution of the Vitamin D receptor and 1α-hydroxylase in human brain.J. Chem. Neuroanat.2921–30. 10.1016/j.jchemneu.2004.08.006
16
GowdaU.MutowoM. P.SmithB. J.WlukaA. E.RenzahoA. M. N. (2015). Vitamin D supplementation to reduce depression in adults: meta-analysis of randomized controlled trials.Nutrition31421–429. 10.1016/j.nut.2014.06.017
17
HeY.WuZ.LanT.WangY.TianY.ChenX.et al (2020). The 25(OH)D/VDR signaling may play a role in major depression.Biochem. Biophys. Res. Commun.523405–410. 10.1016/j.bbrc.2019.12.071
18
HolickM. F.BinkleyN. C.Bischoff-FerrariH. A.GordonC. M.HanleyD. A.HeaneyR. P.et al (2011). Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline.J. Clin. Endocrinol. Metab.961911–1930. 10.1210/jc.2011-0385
19
JakovacH. (2020). COVID-19 and vitamin D—is there a link and an opportunity for intervention?Am. J. Physiol. Endocrinol. Metab.318:E589. 10.1152/ajpendo.00138.2020
20
JonesK. S.AssarS.HarnpanichD.BouillonR.LambrechtsD.PrenticeA.et al (2014). 25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype.J. Clin. Endocrinol. Metab.993373–3381. 10.1210/jc.2014-1714
21
JonesK. S.RedmondJ.FulfordA. J.JarjouL.ZhouB.PrenticeA.et al (2017). Diurnal rhythms of vitamin D binding protein and total and free vitamin D metabolites.J. Steroid Biochem. Mol. Biol.172130–135. 10.1016/j.jsbmb.2017.07.015
22
JordeR.SneveM.HutchinsonM.EmausN.FigenschauY.GrimnesG. (2010). Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study.Am. J. Epidemiol.171903–908. 10.1093/aje/kwq005
23
JuS.-Y.LeeY.-J.JeongS.-N. (2013). Serum 25-hydroxyvitamin D levels and the risk of depression: a systematic review and meta-analysis.J. Nutr. Health Aging17447–455. 10.1007/s12603-012-0418-0
24
KanekoI.SabirM. S.DussikC. M.WhitfieldG. K.KarrysA.HsiehJ.-C.et al (2015). 1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D.FASEB J.294023–4035. 10.1096/fj.14-269811
25
KazemiA.MohammadiV.AghababaeeS. K.GolzarandM.ClarkC. C. T.BabajafariS. (2021). Association of vitamin D status with SARS-CoV-2 infection or COVID-19 severity: a systematic review and meta-analysis.Adv. Nutr.10.1093/advances/nmab012
26
KennelK. A.DrakeM. T.HurleyD. L. (2010). Vitamin D deficiency in adults: when to test and how to treat.Mayo Clin. Proc.85752–757; quiz 757–758. 10.4065/mcp.2010.0138
27
KöhnkeC.HerrmannM.BergerK. (2020). Associations of major depressive disorder and related clinical characteristics with 25-hydroxyvitamin D levels in middle-aged adults.Nutr. Neurosci.1–10. 10.1080/1028415X.2020.1843892
28
KontoangelosK.EconomouM.PapageorgiouC. (2020). Mental health effects of COVID-19 pandemia: a review of clinical and psychological traits.Psychiatry Investig.17491–505. 10.30773/pi.2020.0161
29
LeonardB.MaesM. (2012). Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression.Neurosci. Biobehav. Rev.36764–785. 10.1016/j.neubiorev.2011.12.005
30
LiH.SunD.WangA.PanH.FengW.NgC. H.et al (2019). Serum 25-hydroxyvitamin D levels and depression in older adults: a dose–response meta-analysis of prospective cohort studies.Am. J. Geriatr. Psychiatry271192–1202. 10.1016/j.jagp.2019.05.022
31
LippiG.FerrariA.TargherG. (2021). Is COVID-19 lockdown associated with vitamin D deficiency?Eur. J. Public Health10.1093/eurpub/ckab004
32
LipsP. (2007). Relative value of 25(OH)D and 1,25(OH)2D measurements.J. Bone Miner. Res.221668–1671. 10.1359/jbmr.070716
33
LiuN.SunJ.WangX.ZhangT.ZhaoM.LiH. (2021). Low vitamin D status is associated with coronavirus disease 2019 outcomes: a systematic review and meta-analysis.Int. J. Infect. Dis.10458–64. 10.1016/j.ijid.2020.12.077
34
LuoJ.QuanZ.LinS.CuiL. (2018). The association between blood concentration of 25- hydroxyvitamin D and sarcopenia: a meta-analysis.Asia Pac. J. Clin. Nutr.271258–1270. 10.6133/apjcn.201811_27(6).0013
35
LuoM.GuoL.YuM.JiangW.WangH. (2020). The psychological and mental impact of coronavirus disease 2019 (COVID-19) on medical staff and general public – a systematic review and meta-analysis.Psychiatry Res.291:113190. 10.1016/j.psychres.2020.113190
36
MacdonaldH. M.MavroeidiA.FraserW. D.DarlingA. L.BlackA. J.AucottL.et al (2011). Sunlight and dietary contributions to the seasonal vitamin D status of cohorts of healthy postmenopausal women living at northerly latitudes: a major cause for concern?Osteoporos. Int.222461–2472. 10.1007/s00198-010-1467-z
37
MarikP. E.KoryP.VaronJ. (2020). Does vitamin D status impact mortality from SARS-CoV-2 infection?Med. Drug Discov.6:100041. 10.1016/j.medidd.2020.100041
38
MehtaA.SoniV. K.SharmaK.RatreY. K.ShuklaD.SinghA. K.et al (2021). Finding Horcrux of psychiatric symptoms in COVID-19: deficiencies of amino acids and vitamin D.Asian J. Psychiatr.55:102523. 10.1016/j.ajp.2020.102523
39
MitchellF. (2020). Vitamin-D and COVID-19: do deficient risk a poorer outcome?Lancet Diabetes Endocrinol.8:570. 10.1016/S2213-8587(20)30183-2
40
Mocayar MarónF. J.FerderL.ReiterR. J.ManuchaW. (2020). Daily and seasonal mitochondrial protection: unraveling common possible mechanisms involving vitamin D and melatonin.J. Steroid Biochem. Mol. Biol.199:105595. 10.1016/j.jsbmb.2020.105595
41
MokC. K.NgY. L.AhidjoB. A.LeeR. C. H.LoeM. W. C.LiuJ.et al (2020). Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis.bioRxiv [Preprint]10.1101/2020.06.21.162396
42
MorrisG.BerkM. (2015). The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders.BMC Med.13:68. 10.1186/s12916-015-0310-y
43
MuscogiuriG.BarreaL.ScannapiecoM.Di SommaC.ScacchiM.AimarettiG.et al (2019). The lullaby of the sun: the role of vitamin D in sleep disturbance.Sleep Med.54262–265. 10.1016/j.sleep.2018.10.033
44
NamiM.GadadB. S.ChongL.GhummanU.MisraA.GadadS. S.et al (2020). The interrelation of neurological and psychological symptoms of COVID-19: risks and remedies.J. Clin. Med.9:2624. 10.3390/jcm9082624
45
OkerekeO. I.ReynoldsC. F.MischoulonD.ChangG.VyasC. M.CookN. R.et al (2020). Effect of long-term vitamin D3 supplementation vs placebo on risk of depression or clinically relevant depressive symptoms and on change in mood scores: a randomized clinical trial.JAMA324471–480. 10.1001/jama.2020.10224
46
OliveriB.MastagliaS. R.BritoG. M.SeijoM.KellerG. A.SomozaJ.et al (2015). Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: a pharmacokinetic approach.Eur. J. Clin. Nutr.69697–702. 10.1038/ejcn.2015.16
47
PanareseA.ShahiniE. (2020). Letter: Covid-19, and vitamin D.Aliment. Pharmacol. Ther.51993–995. 10.1111/apt.15752
48
PatrickR. P.AmesB. N. (2015). Vitamin D and the omega-3 fatty acids control serotonin synthesis and action, part 2: relevance for ADHD, bipolar disorder, schizophrenia, and impulsive behavior.FASEB J.292207–2222. 10.1096/fj.14-268342
49
PereiraM.Dantas DamascenaA.Galvão AzevedoL. M.de Almeida OliveiraT.da Mota SantanaJ. (2020). Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis.Crit. Rev. Food Sci. Nutr.1–9. 10.1080/10408398.2020.1841090
50
PetrelliF.LucianiA.PeregoG.DogniniG.ColombelliP. L.GhidiniA. (2021). Therapeutic and prognostic role of vitamin D for COVID-19 infection: a systematic review and meta-analysis of 43 observational studies.J. Steroid Biochem. Mol. Biol.211:105883. 10.1016/j.jsbmb.2021.105883
51
RobbC. E.de JagerC. A.Ahmadi-AbhariS.GiannakopoulouP.Udeh-MomohC.McKeandJ.et al (2020). Associations of social isolation with anxiety and depression during the early COVID-19 pandemic: a survey of older adults in London, UK.Front. Psychiatry11:591120. 10.3389/fpsyt.2020.591120
52
SabirM. S.HausslerM. R.MallickS.KanekoI.LucasD. A.HausslerC. A.et al (2018). Optimal vitamin D spurs serotonin: 1,25-dihydroxyvitamin D represses serotonin reuptake transport (SERT) and degradation (MAO-A) gene expression in cultured rat serotonergic neuronal cell lines.Genes Nutr.13:19. 10.1186/s12263-018-0605-7
53
SantiniZ. I.JoseP. E.York CornwellE.KoyanagiA.NielsenL.HinrichsenC.et al (2020). Social disconnectedness, perceived isolation, and symptoms of depression and anxiety among older Americans (NSHAP): a longitudinal mediation analysis.Lancet Public Health5e62–e70. 10.1016/S2468-2667(19)30230-0
54
SmithB. J.LimM. H. (2020). How the COVID-19 pandemic is focusing attention on loneliness and social isolation.Public Health Res. Pract.30:3022008. 10.17061/phrp3022008
55
SongB. M.KimH. C.RheeY.YoumY.KimC. O. (2016). Association between serum 25-hydroxyvitamin D concentrations and depressive symptoms in an older Korean population: a cross-sectional study.J. Affect. Disord.189357–364. 10.1016/j.jad.2015.09.043
56
SpeddingS. (2014). Vitamin D and depression: a systematic review and meta-analysis comparing studies with and without biological flaws.Nutrients61501–1518. 10.3390/nu6041501
57
TeshomeA.AdaneA.GirmaB.MekonnenZ. A. (2021). The impact of vitamin D level on COVID-19 infection: systematic review and meta-analysis.Front. Public Health9:624559. 10.3389/fpubh.2021.624559
58
VellekkattF.MenonV.RajappaM.SahooJ. (2020). Effect of adjunctive single dose parenteral vitamin D supplementation in major depressive disorder with concurrent vitamin D deficiency: a double-blind randomized placebo-controlled trial.J. Psychiatr. Res.129250–256. 10.1016/j.jpsychires.2020.07.037
59
VidgrenM.VirtanenJ. K.TolmunenT.NurmiT.TuomainenT.-P.VoutilainenS.et al (2018). Serum concentrations of 25-hydroxyvitamin D and depression in a general middle-aged to elderly population in Finland.J. Nutr. Health Aging22159–164. 10.1007/s12603-017-0948-6
60
WackerM.HolickM. F. (2013). Sunlight and vitamin D: a global perspective for health.Dermato Endocrinol.551–108. 10.4161/derm.24494
61
WangC.PanR.WanX.TanY.XuL.HoC. S.et al (2020). Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China.Int. J. Environ. Res. Public Health17:1729. 10.3390/ijerph17051729
62
XiongJ.LipsitzO.NasriF.LuiL. M. W.GillH.PhanL.et al (2020). Impact of COVID-19 pandemic on mental health in the general population: a systematic review.J. Affect. Disord.27755–64. 10.1016/j.jad.2020.08.001
63
YaoY.FuS.ZhangH.LiN.ZhuQ.ZhangF.et al (2018). The prevalence of depressive symptoms in Chinese longevous persons and its correlation with vitamin D status.BMC Geriatrics18:198. 10.1186/s12877-018-0886-0
64
ZhouY.-F.LuoB.-A.QinL.-L. (2019). The association between vitamin D deficiency and community-acquired pneumonia: a meta-analysis of observational studies.Medicine (Baltimore)98:e17252. 10.1097/MD.0000000000017252
65
ZhuC.ZhangY.WangT.LinY.YuJ.XiaQ.et al (2020). Vitamin D supplementation improves anxiety but not depression symptoms in patients with vitamin D deficiency.Brain Behav.10:e01760. 10.1002/brb3.1760
Summary
Keywords
vitamin D, cholecalciferol, depressive symptoms, social isolation, pandemics, COVID-19
Citation
Ceolin G, Mano GPR, Hames NS, Antunes LC, Brietzke E, Rieger DK and Moreira JD (2021) Vitamin D, Depressive Symptoms, and Covid-19 Pandemic. Front. Neurosci. 15:670879. doi: 10.3389/fnins.2021.670879
Received
22 February 2021
Accepted
12 April 2021
Published
13 May 2021
Volume
15 - 2021
Edited by
Vittorio Calabrese, University of Catania, Italy
Reviewed by
Keiko Iwata, University of Fukui, Japan; Reza Rastmanesh, Independent researcher, Tehran, Iran
Updates
Copyright
© 2021 Ceolin, Mano, Hames, Antunes, Brietzke, Rieger and Moreira.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Gilciane Ceolin, nutrigil@live.com
This article was submitted to Neuroenergetics, Nutrition and Brain Health, a section of the journal Frontiers in Neuroscience
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.